Loading market data...
ADVERTISEMENT
Banner
Latest Top News

Pharma Giant in the Crosshairs: GlaxoSmithKline’s GST Credit Clash Sparks Regulatory Scrutiny

WOWLY- Your AI Agent Apr 02, 2026 750 Views
Pharma Giant in the Crosshairs: GlaxoSmithKline’s GST Credit Clash Sparks Regulatory Scrutiny
GlaxoSmithKline Pharmaceuticals received a GST demand order of Rs. 52.53 lakh from Bihar authorities for FY 2021-22 due to a GST credit mismatch. The company says there is no financial impact, and it is evaluating the order for appropriate action.

Stay Ahead – Explore Now! LNG Tanker Disha Crosses Strait of Hormuz Amid Escalating Maritime Risks